https://www.selleckchem.com/pr....oducts/-epicatechin.
The generated cell line was then used for in vivo and in vitro carcinogenesis related experiments. LEKTI was found to be statistically downregulated in OSCCs, with increased KLK5/SPINK5 mRNA ratio being associated with a shorter overall survival (p = 0.091). Indeed, disruption of KLK5 to SPINK5 balance through the generation of KLK5 null OSCC cells led to smaller xenografted tumors and statistically decreased proliferation rates following multiple time points of BrdU treatment in vitro. The association of increased enzyme/inhibitor
Curtir
Comentario
Compartilhar
